DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

173 hedge funds and large institutions have $1.4B invested in Dicerna Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 56 increasing their positions, 66 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
173
Holders Change
+1
Holders Change %
+0.58%
% of All Funds
3.07%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
28
Increased
56
Reduced
66
Closed
27
Calls
$1.51M
Puts
$4.79M
Net Calls
-$3.28M
Net Calls Change
+$5.06M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$52.1M
2
UBS Group
2
UBS Group
Switzerland
$48.5M
3
WP
3
Woodline Partners
California
$29.9M
4
CCM
4
CAAS Capital Management
New York
$10.8M
5
Goldman Sachs
5
Goldman Sachs
New York
$23.8M

Top Sellers

1
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$67.9M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$95.1M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$15.1M
4
BM
4
Bridger Management
New York
$0
5
State Street
5
State Street
Massachusetts
$62.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Advisers
26
Two Sigma Advisers
New York
$11.7M -$2.72M -123,300 -19%
CCM
27
Camber Capital Management
Massachusetts
$11.6M – – –
Charles Schwab
28
Charles Schwab
California
$11.4M +$226K +10,269 +2%
CCM
29
CAAS Capital Management
New York
$10.8M +$10.8M +489,765 New
EMFAT
30
Emerald Mutual Fund Advisers Trust
Pennsylvania
$10.2M +$2.43M +110,089 +31%
Nuveen Asset Management
31
Nuveen Asset Management
Illinois
$8.19M -$730K -33,119 -8%
Millennium Management
32
Millennium Management
New York
$8.1M +$2.75M +124,919 +51%
Carson Wealth (CWM LLC)
33
Carson Wealth (CWM LLC)
Nebraska
$8.08M – – –
Axa
34
Axa
France
$8.05M +$1.99M +90,532 +33%
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$7.47M +$4.84M +219,765 +184%
UBS AM
36
UBS AM
Illinois
$7.4M -$396K -17,976 -5%
PAI
37
Palo Alto Investors
California
$7.31M – – –
PHP
38
Parkman Healthcare Partners
Connecticut
$7.3M +$124K +5,650 +2%
PAM
39
Panagora Asset Management
Massachusetts
$6.62M +$5.02M +228,035 +315%
Connor, Clark & Lunn Investment Management (CC&L)
40
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$6.61M +$42.5K +1,930 +0.6%
Invesco
41
Invesco
Georgia
$6.52M -$1.21M -55,078 -16%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$6.14M +$45.3K +2,057 +0.7%
Schroder Investment Management Group
43
Schroder Investment Management Group
United Kingdom
$5.27M +$98.1K +4,455 +2%
SCM
44
Silverarc Capital Management
Massachusetts
$5.01M +$5.01M +227,388 New
SFM
45
Sphera Funds Management
Israel
$4.78M +$375K +17,000 +9%
VOYA Investment Management
46
VOYA Investment Management
Georgia
$4.72M -$1.11M -50,217 -19%
Bank of America
47
Bank of America
North Carolina
$3.92M -$1.27M -57,511 -24%
Hudson Bay Capital Management
48
Hudson Bay Capital Management
Connecticut
$3.75M -$3.52M -160,000 -48%
SAM
49
Silvercrest Asset Management
New York
$3.65M -$583K -26,477 -14%
Wells Fargo
50
Wells Fargo
California
$3.35M -$125K -5,681 -4%
1
2
3 4 5